167 related articles for article (PubMed ID: 36687217)
21. Curcumin attenuates the release of pro-inflammatory cytokines in lipopolysaccharide-stimulated BV2 microglia.
Jin CY; Lee JD; Park C; Choi YH; Kim GY
Acta Pharmacol Sin; 2007 Oct; 28(10):1645-51. PubMed ID: 17883952
[TBL] [Abstract][Full Text] [Related]
22. Nuclear factor kappaB transcription factors are coexpressed and convey a poor outcome in ovarian cancer.
Annunziata CM; Stavnes HT; Kleinberg L; Berner A; Hernandez LF; Birrer MJ; Steinberg SM; Davidson B; Kohn EC
Cancer; 2010 Jul; 116(13):3276-84. PubMed ID: 20564628
[TBL] [Abstract][Full Text] [Related]
23. Suppression of iNOS and COX-2 expression by flavokawain A via blockade of NF-κB and AP-1 activation in RAW 264.7 macrophages.
Kwon DJ; Ju SM; Youn GS; Choi SY; Park J
Food Chem Toxicol; 2013 Aug; 58():479-86. PubMed ID: 23727179
[TBL] [Abstract][Full Text] [Related]
24. Curcumin inhibits phorbol ester-induced up-regulation of cyclooxygenase-2 and matrix metalloproteinase-9 by blocking ERK1/2 phosphorylation and NF-kappaB transcriptional activity in MCF10A human breast epithelial cells.
Lee KW; Kim JH; Lee HJ; Surh YJ
Antioxid Redox Signal; 2005; 7(11-12):1612-20. PubMed ID: 16356124
[TBL] [Abstract][Full Text] [Related]
25. Febuxostat Inhibits MPP+-Induced Inflammatory Response Through Inhibiting the JNK/NF-κB Pathway in Astrocytes.
Yan W; Zhang Y; Hu L; Li Q; Zhou H
Neurotox Res; 2021 Jun; 39(3):566-574. PubMed ID: 33443645
[TBL] [Abstract][Full Text] [Related]
26. Chlorogenic Acid Potentiates the Anti-Inflammatory Activity of Curcumin in LPS-Stimulated THP-1 Cells.
Bisht A; Dickens M; Rutherfurd-Markwick K; Thota R; Mutukumira AN; Singh H
Nutrients; 2020 Sep; 12(9):. PubMed ID: 32899726
[TBL] [Abstract][Full Text] [Related]
27. Curcumin inhibits tumor growth and angiogenesis in ovarian carcinoma by targeting the nuclear factor-kappaB pathway.
Lin YG; Kunnumakkara AB; Nair A; Merritt WM; Han LY; Armaiz-Pena GN; Kamat AA; Spannuth WA; Gershenson DM; Lutgendorf SK; Aggarwal BB; Sood AK
Clin Cancer Res; 2007 Jun; 13(11):3423-30. PubMed ID: 17545551
[TBL] [Abstract][Full Text] [Related]
28. Curcumin potentiates the antitumor effects of 5-FU in treatment of esophageal squamous carcinoma cells through downregulating the activation of NF-κB signaling pathway in vitro and in vivo.
Tian F; Fan T; Zhang Y; Jiang Y; Zhang X
Acta Biochim Biophys Sin (Shanghai); 2012 Oct; 44(10):847-55. PubMed ID: 23017833
[TBL] [Abstract][Full Text] [Related]
29. Curcumin Ameliorates Reserpine-Induced Gastrointestinal Mucosal Lesions Through Inhibiting IκB-α/NF-κB Pathway and Regulating Expression of Vasoactive Intestinal Peptide and Gastrin in Rats.
Long L; Wang J; Chen N; Zheng S; Shi L; Xu Y; Luo C; Deng Y
J Med Food; 2016 Jun; 19(6):528-34. PubMed ID: 26872103
[TBL] [Abstract][Full Text] [Related]
30. Curcumin potentiates antitumor activity of gemcitabine in an orthotopic model of pancreatic cancer through suppression of proliferation, angiogenesis, and inhibition of nuclear factor-kappaB-regulated gene products.
Kunnumakkara AB; Guha S; Krishnan S; Diagaradjane P; Gelovani J; Aggarwal BB
Cancer Res; 2007 Apr; 67(8):3853-61. PubMed ID: 17440100
[TBL] [Abstract][Full Text] [Related]
31. Inhibition of IkappaB kinase-nuclear factor-kappaB signaling pathway by 3,5-bis(2-flurobenzylidene)piperidin-4-one (EF24), a novel monoketone analog of curcumin.
Kasinski AL; Du Y; Thomas SL; Zhao J; Sun SY; Khuri FR; Wang CY; Shoji M; Sun A; Snyder JP; Liotta D; Fu H
Mol Pharmacol; 2008 Sep; 74(3):654-61. PubMed ID: 18577686
[TBL] [Abstract][Full Text] [Related]
32. Design and synthesis of methoxyphenyl- and coumarin-based chalcone derivatives as anti-inflammatory agents by inhibition of NO production and down-regulation of NF-κB in LPS-induced RAW264.7 macrophage cells.
Emam SH; Sonousi A; Osman EO; Hwang D; Kim GD; Hassan RA
Bioorg Chem; 2021 Feb; 107():104630. PubMed ID: 33476864
[TBL] [Abstract][Full Text] [Related]
33. Curcumin inhibits cell proliferation and promotes apoptosis in human osteoclastoma cell through MMP-9, NF-κB and JNK signaling pathways.
Cao F; Liu T; Xu Y; Xu D; Feng S
Int J Clin Exp Pathol; 2015; 8(6):6037-45. PubMed ID: 26261481
[TBL] [Abstract][Full Text] [Related]
34. NF-kappaB mediates MPP+-induced apoptotic cell death in neuroblastoma cells SH-EP1 through JNK and c-Jun/AP-1.
Yang HJ; Wang L; Xia YY; Chang PN; Feng ZW
Neurochem Int; 2010 Jan; 56(1):128-34. PubMed ID: 19778565
[TBL] [Abstract][Full Text] [Related]
35. Curcumin derivative, 2,6-bis(2-fluorobenzylidene)cyclohexanone (MS65) inhibits interleukin-6 production through suppression of NF-κB and MAPK pathways in histamine-induced human keratinocytes cell (HaCaT).
Razali NA; Nazarudin NA; Lai KS; Abas F; Ahmad S
BMC Complement Altern Med; 2018 Jul; 18(1):217. PubMed ID: 30012134
[TBL] [Abstract][Full Text] [Related]
36. Resveratrol inhibits inflammatory responses via the mammalian target of rapamycin signaling pathway in cultured LPS-stimulated microglial cells.
Zhong LM; Zong Y; Sun L; Guo JZ; Zhang W; He Y; Song R; Wang WM; Xiao CJ; Lu D
PLoS One; 2012; 7(2):e32195. PubMed ID: 22363816
[TBL] [Abstract][Full Text] [Related]
37. Blockade of nuclear factor-kappaB signaling pathway and anti-inflammatory activity of cardamomin, a chalcone analog from Alpinia conchigera.
Lee JH; Jung HS; Giang PM; Jin X; Lee S; Son PT; Lee D; Hong YS; Lee K; Lee JJ
J Pharmacol Exp Ther; 2006 Jan; 316(1):271-8. PubMed ID: 16183703
[TBL] [Abstract][Full Text] [Related]
38. Curcumin suppresses the paclitaxel-induced nuclear factor-kappaB in breast cancer cells and potentiates the growth inhibitory effect of paclitaxel in a breast cancer nude mice model.
Kang HJ; Lee SH; Price JE; Kim LS
Breast J; 2009; 15(3):223-9. PubMed ID: 19645775
[TBL] [Abstract][Full Text] [Related]
39. Characterization of a novel curcumin analog P1 as potent inhibitor of the NF-κB signaling pathway with distinct mechanisms.
Peng YM; Zheng JB; Zhou YB; Li J
Acta Pharmacol Sin; 2013 Jul; 34(7):939-50. PubMed ID: 23603982
[TBL] [Abstract][Full Text] [Related]
40. (E)-3-(3,4-Dimethoxyphenyl)-1-(5-hydroxy-2,2-dimethyl-2H-chromen-6-yl)prop-2-en-1-one ameliorates the collagen-arthritis via blocking ERK/JNK and NF-κB signaling pathway.
Li X; Peng F; Xie C; Wu W; Han X; Chen L
Int Immunopharmacol; 2013 Dec; 17(4):1125-33. PubMed ID: 24135236
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
